85 related articles for article (PubMed ID: 21501080)
1. Effect of tempol on diabetes-induced decreases in retinal blood flow in the mouse.
Yadav AS; Harris NR
Curr Eye Res; 2011 May; 36(5):456-61. PubMed ID: 21501080
[TBL] [Abstract][Full Text] [Related]
2. Exogenous SOD mimetic tempol ameliorates the early retinal changes reestablishing the redox status in diabetic hypertensive rats.
Rosales MA; Silva KC; Lopes de Faria JB; Lopes de Faria JM
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4327-36. PubMed ID: 20335612
[TBL] [Abstract][Full Text] [Related]
3. Superoxide dismutase mimetic drug tempol aggravates anti-GBM antibody-induced glomerulonephritis in mice.
Lu H; Zhen J; Wu T; Peng A; Ye T; Wang T; Yu X; Vaziri ND; Mohan C; Zhou XJ
Am J Physiol Renal Physiol; 2010 Aug; 299(2):F445-52. PubMed ID: 20504883
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 20-HETE attenuates diabetes-induced decreases in retinal hemodynamics.
Wang Z; Yadav AS; Leskova W; Harris NR
Exp Eye Res; 2011 Jul; 93(1):108-13. PubMed ID: 21658386
[TBL] [Abstract][Full Text] [Related]
6. Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants.
Kowluru RA; Odenbach S
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4161-6. PubMed ID: 15505070
[TBL] [Abstract][Full Text] [Related]
7. Double-edged action of SOD mimetic in diabetic nephropathy.
Asaba K; Tojo A; Onozato ML; Goto A; Fujita T
J Cardiovasc Pharmacol; 2007 Jan; 49(1):13-9. PubMed ID: 17261958
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of streptozotocin-induced microvascular changes in the mouse retina with the endothelin receptor A antagonist atrasentan.
Wang Z; Yadav AS; Leskova W; Harris NR
Exp Eye Res; 2010 Nov; 91(5):670-5. PubMed ID: 20727883
[TBL] [Abstract][Full Text] [Related]
9. Acute hyperglycemia-induced endothelial dysfunction in retinal arterioles in cats.
Sogawa K; Nagaoka T; Izumi N; Nakabayashi S; Yoshida A
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2648-55. PubMed ID: 20042654
[TBL] [Abstract][Full Text] [Related]
10. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy.
Bursell SE; Clermont AC; Kinsley BT; Simonson DC; Aiello LM; Wolpert HA
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):886-97. PubMed ID: 8603873
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of tempol on retinal ganglion cells in a partial optic nerve crush rat model with and without iron load.
Thaler S; Fiedorowicz M; Rejdak R; Choragiewicz TJ; Sulejczak D; Stopa P; Zarnowski T; Zrenner E; Grieb P; Schuettauf F
Exp Eye Res; 2010 Feb; 90(2):254-60. PubMed ID: 19883642
[TBL] [Abstract][Full Text] [Related]
12. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of diabetes-induced retinal vasoconstriction by a thromboxane receptor antagonist.
Wright WS; Messina JE; Harris NR
Exp Eye Res; 2009 Jan; 88(1):106-12. PubMed ID: 18996116
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats.
Kowluru RA; Menon B; Gierhart DL
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1645-51. PubMed ID: 18385086
[TBL] [Abstract][Full Text] [Related]
15. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
16. Retinal blood flow in normal and diabetic dogs.
Small KW; Stefánsson E; Hatchell DL
Invest Ophthalmol Vis Sci; 1987 Apr; 28(4):672-5. PubMed ID: 3557871
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients.
Aiello LP; Clermont A; Arora V; Davis MD; Sheetz MJ; Bursell SE
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):86-92. PubMed ID: 16384948
[TBL] [Abstract][Full Text] [Related]
18. Renal and metabolic effects of tempol in obese ZSF1 rats--distinct role for superoxide and hydrogen peroxide in diabetic renal injury.
Rafikova O; Salah EM; Tofovic SP
Metabolism; 2008 Oct; 57(10):1434-44. PubMed ID: 18803950
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction.
Woodman OL; Malakul W; Cao AH; Xu Q; Ritchie RH
Life Sci; 2008 Apr; 82(15-16):847-54. PubMed ID: 18302965
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats.
Arnal E; Miranda M; Johnsen-Soriano S; Alvarez-Nölting R; Díaz-Llopis M; Araiz J; Cervera E; Bosch-Morell F; Romero FJ
Curr Eye Res; 2009 Nov; 34(11):928-38. PubMed ID: 19958109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
